BlackRock Institutional Trust Company, N.A. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 36 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$364,000
+167.6%
23,346
+123.6%
0.00%
Q3 2016$136,000
+88.9%
10,4430.0%0.00%
Q2 2016$72,000
-75.0%
10,443
-65.8%
0.00%
Q1 2016$288,000
-11.9%
30,510
-6.1%
0.00%
Q4 2015$327,000
-12.8%
32,499
+24.2%
0.00%
Q3 2015$375,00026,1770.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders